Literature DB >> 27512075

Identification of Residues That Affect Oligomerization and/or Enzymatic Activity of Influenza Virus H5N1 Neuraminidase Proteins.

Meiling Dai1, Hongbo Guo1, Jos C F M Dortmans1, Jojanneke Dekkers1, Johan Nordholm2, Robert Daniels2, Frank J M van Kuppeveld1, Erik de Vries1, Cornelis A M de Haan3.   

Abstract

UNLABELLED: Influenza A virus (IAV) attachment to and release from sialoside receptors is determined by the balance between hemagglutinin (HA) and neuraminidase (NA). The molecular determinants that mediate the specificity and activity of NA are still poorly understood. In this study, we aimed to design the optimal recombinant soluble NA protein to identify residues that affect NA enzymatic activity. To this end, recombinant soluble versions of four different NA proteins from H5N1 viruses were compared with their full-length counterparts. The soluble NA ectodomains were fused to three commonly used tetramerization domains. Our results indicate that the particular oligomerization domain used does not affect the Km value but may affect the specific enzymatic activity. This particularly holds true when the stalk domain is included and for NA ectodomains that display a low intrinsic ability to oligomerize. NA ectodomains extended with a Tetrabrachion domain, which forms a nearly parallel four-helix bundle, better mimicked the enzymatic properties of full-length proteins than when other coiled-coil tetramerization domains were used, which probably distort the stalk domain. Comparison of different NA proteins and mutagenic analysis of recombinant soluble versions thereof resulted in the identification of several residues that affected oligomerization of the NA head domain (position 95) and therefore the specific activity or sialic acid binding affinity (Km value; positions 252 and 347). This study demonstrates the potential of using recombinant soluble NA proteins to reveal determinants of NA assembly and enzymatic activity. IMPORTANCE: The IAV HA and NA glycoproteins are important determinants of host tropism and pathogenicity. However, NA is relatively understudied compared to HA. Analysis of soluble versions of these glycoproteins is an attractive way to study their activities, as they are easily purified from cell culture media and applied in downstream assays. In the present study, we analyzed the enzymatic activity of different NA ectodomains with three commonly used tetramerization domains and compared them with full-length NA proteins. By performing a mutagenic analysis, we identified several residues that affected NA assembly, activity, and/or substrate binding. In addition, our results indicate that the design of the recombinant soluble NA protein, including the particular tetramerization domain, is an important determinant for maintaining the enzymatic properties within the head domain. NA ectodomains extended with a Tetrabrachion domain better mimicked the full-length proteins than when the other tetramerization domains were used.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27512075      PMCID: PMC5044851          DOI: 10.1128/JVI.01346-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic.

Authors:  Niall P A S Johnson; Juergen Mueller
Journal:  Bull Hist Med       Date:  2002       Impact factor: 1.314

Review 2.  Avian influenza A (H5N1) infection in humans.

Authors:  John H Beigel; Jeremy Farrar; Aye Maung Han; Frederick G Hayden; Randy Hyer; Menno D de Jong; Sorasak Lochindarat; Thi Kim Tien Nguyen; Tran Hien Nguyen; Tinh Hien Tran; Angus Nicoll; Sok Touch; Kwok-Yung Yuen
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

3.  The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity.

Authors:  Robert P de Vries; Erik de Vries; Berend Jan Bosch; Raoul J de Groot; Peter J M Rottier; Cornelis A M de Haan
Journal:  Virology       Date:  2010-05-02       Impact factor: 3.616

4.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

5.  A revision of the system of nomenclature for influenza viruses: a WHO memorandum.

Authors: 
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

Review 6.  Avian influenza virus (H5N1): a threat to human health.

Authors:  J S Malik Peiris; Menno D de Jong; Yi Guan
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

Review 7.  Influenza neuraminidase.

Authors:  Gillian M Air
Journal:  Influenza Other Respir Viruses       Date:  2011-11-16       Impact factor: 4.380

8.  The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.

Authors:  W P Burmeister; R W Ruigrok; S Cusack
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

9.  Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay.

Authors:  Marua Prevato; Ilaria Ferlenghi; Alessandra Bonci; Yasushi Uematsu; Giulia Anselmi; Fabiola Giusti; Sylvie Bertholet; Francois Legay; John Laird Telford; Ethan C Settembre; Domenico Maione; Roberta Cozzi
Journal:  PLoS One       Date:  2015-08-17       Impact factor: 3.240

10.  New world bats harbor diverse influenza A viruses.

Authors:  Suxiang Tong; Xueyong Zhu; Yan Li; Mang Shi; Jing Zhang; Melissa Bourgeois; Hua Yang; Xianfeng Chen; Sergio Recuenco; Jorge Gomez; Li-Mei Chen; Adam Johnson; Ying Tao; Cyrille Dreyfus; Wenli Yu; Ryan McBride; Paul J Carney; Amy T Gilbert; Jessie Chang; Zhu Guo; Charles T Davis; James C Paulson; James Stevens; Charles E Rupprecht; Edward C Holmes; Ian A Wilson; Ruben O Donis
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

View more
  18 in total

1.  Structure of an Influenza A virus N9 neuraminidase with a tetrabrachion-domain stalk.

Authors:  Victor A Streltsov; Peter M Schmidt; Jennifer L McKimm-Breschkin
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-01-23       Impact factor: 1.056

2.  Human Cellular Retinol Binding Protein II Forms a Domain-Swapped Trimer Representing a Novel Fold and a New Template for Protein Engineering.

Authors:  Alireza Ghanbarpour; Elizabeth M Santos; Cody Pinger; Zahra Assar; Seyedmehdi Hossaini Nasr; Chrysoula Vasileiou; Dana Spence; Babak Borhan; James H Geiger
Journal:  Chembiochem       Date:  2020-08-14       Impact factor: 3.164

3.  Mutation of the Second Sialic Acid-Binding Site, Resulting in Reduced Neuraminidase Activity, Preceded the Emergence of H7N9 Influenza A Virus.

Authors:  Meiling Dai; Ryan McBride; Jos C F M Dortmans; Wenjie Peng; Mark J G Bakkers; Raoul J de Groot; Frank J M van Kuppeveld; James C Paulson; Erik de Vries; Cornelis A M de Haan
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

4.  The Potential of Neuraminidase as an Antigen for Nasal Vaccines To Increase Cross-Protection against Influenza Viruses.

Authors:  Atsushi Kawai; Yasuyuki Yamamoto; Takuto Nogimori; Kohei Takeshita; Takuya Yamamoto; Yasuo Yoshioka
Journal:  J Virol       Date:  2021-08-11       Impact factor: 5.103

5.  Design of the Recombinant Influenza Neuraminidase Antigen Is Crucial for Its Biochemical Properties and Protective Efficacy.

Authors:  Jin Gao; Laura Klenow; Lisa Parsons; Tahir Malik; Je-Nie Phue; Zhizeng Gao; Stephen G Withers; John Cipollo; Robert Daniels; Hongquan Wan
Journal:  J Virol       Date:  2021-10-06       Impact factor: 5.103

6.  Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.

Authors:  E R Job; M Schotsaert; L I Ibañez; A Smet; T Ysenbaert; K Roose; M Dai; C A M de Haan; H Kleanthous; T U Vogel; X Saelens
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

7.  Substrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity.

Authors:  Wenjuan Du; Meiling Dai; Zeshi Li; Geert-Jan Boons; Ben Peeters; Frank J M van Kuppeveld; Erik de Vries; Cornelis A M de Haan
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

8.  Structural restrictions for influenza neuraminidase activity promote adaptation and diversification.

Authors:  Hao Wang; Dan Dou; Henrik Östbye; Rebecca Revol; Robert Daniels
Journal:  Nat Microbiol       Date:  2019-08-26       Impact factor: 17.745

9.  Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics.

Authors:  Meiling Dai; Wenjuan Du; Carles Martínez-Romero; Tim Leenders; Tom Wennekes; Guus F Rimmelzwaan; Frank J M van Kuppeveld; Ron A M Fouchier; Adolfo Garcia-Sastre; Erik de Vries; Cornelis A M de Haan
Journal:  mBio       Date:  2021-05-11       Impact factor: 7.867

10.  Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.

Authors:  Wei Dong; Yoshita Bhide; Federica Sicca; Tjarko Meijerhof; Kate Guilfoyle; Othmar G Engelhardt; Louis Boon; Cornelis A M de Haan; George Carnell; Nigel Temperton; Jacqueline de Vries-Idema; David Kelvin; Anke Huckriede
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.